Overview

A Study to Demonstrate the Analgesic Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Addition to Pregabalin Compared to Pregabalin Alone in Opioid-naïve Subjects Treated With Pregabalin Suffering From Moderate to Severe Pain Due to Diab

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
To show superior analgesic efficacy of OXN PR in addition to a patient's current dose of pregabalin compared to pregabalin alone.
Phase:
Phase 2
Details
Lead Sponsor:
Mundipharma Research GmbH & Co KG
Treatments:
Analgesics
Naloxone
Oxycodone
Pregabalin